These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27686121)

  • 41. Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosa.
    Mdluli KE; Witte PR; Kline T; Barb AW; Erwin AL; Mansfield BE; McClerren AL; Pirrung MC; Tumey LN; Warrener P; Raetz CR; Stover CK
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2178-84. PubMed ID: 16723580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemical characterization and evaluation of potent inhibitors of the Pseudomonas aeruginosa PA01 acetohydroxyacid synthase.
    Cho JH; Lee MY; Baig IA; Ha NR; Kim J; Yoon MY
    Biochimie; 2013 Jul; 95(7):1411-21. PubMed ID: 23523771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fragment library screening identifies hits that bind to the non-catalytic surface of Pseudomonas aeruginosa DsbA1.
    Mohanty B; Rimmer K; McMahon RM; Headey SJ; Vazirani M; Shouldice SR; Coinçon M; Tay S; Morton CJ; Simpson JS; Martin JL; Scanlon MJ
    PLoS One; 2017; 12(3):e0173436. PubMed ID: 28346540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antisense peptide nucleic acid–peptide conjugates for functional analyses of genes in Pseudomonas aeruginosa.
    Maekawa K; Azuma M; Okuno Y; Tsukamoto T; Nishiguchi K; Setsukinai K; Maki H; Numata Y; Takemoto H; Rokushima M
    Bioorg Med Chem; 2015 Nov; 23(22):7234-9. PubMed ID: 26602085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of LasR ligands through a virtual screening approach.
    Skovstrup S; Le Quement ST; Hansen T; Jakobsen TH; Harmsen M; Tolker-Nielsen T; Nielsen TE; Givskov M; Taboureau O
    ChemMedChem; 2013 Jan; 8(1):157-63. PubMed ID: 23203920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.
    Lister PD; Wolter DJ; Wickman PA; Reisbig MD
    J Antimicrob Chemother; 2006 May; 57(5):999-1003. PubMed ID: 16513915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review: Antibiotic discovery in the age of structural biology - a comprehensive overview with special reference to development of drugs for the treatment of Pseudomonas aeruginosa infection.
    Koehnke A; Friedrich RE
    In Vivo; 2015; 29(2):161-7. PubMed ID: 25792642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel ethyl 1,5-disubstituted-1H-pyrazole-3-carboxylates as a new class of antimicrobial agents.
    Radwan AA; Ghorab MM; Alsaid MS; Alanazi FK
    Acta Pharm; 2014 Sep; 64(3):335-44. PubMed ID: 25296679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis and biological evaluation of C(4) substituted monobactams as antibacterial agents against multidrug-resistant Gram-negative bacteria.
    Kou Q; Wang T; Zou F; Zhang S; Chen Q; Yang Y
    Eur J Med Chem; 2018 May; 151():98-109. PubMed ID: 29605810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Description of IMP-31, a novel metallo-β-lactamase found in an ST235 Pseudomonas aeruginosa strain in Western Germany.
    Pfennigwerth N; Geis G; Gatermann SG; Kaase M
    J Antimicrob Chemother; 2015 Jul; 70(7):1973-80. PubMed ID: 25835992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.
    Greipel L; Fischer S; Klockgether J; Dorda M; Mielke S; Wiehlmann L; Cramer N; Tümmler B
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6726-6734. PubMed ID: 27572404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Arabinose 5-phosphate isomerase as a target for antibacterial design: studies with substrate analogues and inhibitors.
    Gabrielli L; Merlo S; Airoldi C; Sperandeo P; Gianera S; Polissi A; Nicotra F; Holler TP; Woodard RW; Cipolla L
    Bioorg Med Chem; 2014 Apr; 22(8):2576-83. PubMed ID: 24680056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthetic ligands that activate and inhibit a quorum-sensing regulator in Pseudomonas aeruginosa.
    Mattmann ME; Geske GD; Worzalla GA; Chandler JR; Sappington KJ; Greenberg EP; Blackwell HE
    Bioorg Med Chem Lett; 2008 May; 18(10):3072-5. PubMed ID: 18083553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New library of pyrazole-imidazo[1,2-α]pyridine molecular conjugates: Synthesis, antibacterial activity and molecular docking studies.
    Ebenezer O; Awolade P; Koorbanally N; Singh P
    Chem Biol Drug Des; 2020 Jan; 95(1):162-173. PubMed ID: 31580533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety.
    Nasr T; Bondock S; Eid S
    Eur J Med Chem; 2014 Sep; 84():491-504. PubMed ID: 25050881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combining topology and sequence design for the discovery of potent antimicrobial peptide dendrimers against multidrug-resistant Pseudomonas aeruginosa.
    Stach M; Siriwardena TN; Köhler T; van Delden C; Darbre T; Reymond JL
    Angew Chem Int Ed Engl; 2014 Nov; 53(47):12827-31. PubMed ID: 25346278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response regulator GacA and transcriptional activator RhlR proteins involved in biofilm formation of Pseudomonas aeruginosa are prospective targets for natural lead molecules: Computational modelling, molecular docking and dynamic simulation studies.
    Skariyachan S; Ravishankar R; Gopal D; Muddebihalkar AG; Uttarkar A; Praveen PKU; Niranjan V
    Infect Genet Evol; 2020 Nov; 85():104448. PubMed ID: 32622078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
    Zavascki AP; Carvalhaes CG; Picão RC; Gales AC
    Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors.
    Liu JJ; Sun J; Fang YB; Yang YA; Jiao RH; Zhu HL
    Org Biomol Chem; 2014 Feb; 12(6):998-1008. PubMed ID: 24382549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.